EUVIMEDEUVIMED entdecken
Crossref

L26/P-445 Reproductive outcomes after elective oocyte cryopreservation: a 10-year epidemiological follow-up study of 17,122 cryopreserved oocytes in Latin America

M. Pereira Valle, C. Lima, T. Andrade, M. Sampaio, M. Del Collado, A. Oliveira

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Pereira Valle und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How have elective fertility preservation (EFP) programmes evolved over the past decade, and are women cryopreserving adequate numbers of oocytes to achieve a live birth? Summary answer Although oocyte survival rates and the number of EFP cycles increased, the number of cryopreserved oocytes remained below that required to achieve a live birth. What is known already The trend toward delaying motherhood is evident and driven by multiple factors, and EFP offers women a strategy to safeguard reproductive potential in anticipation of age-related fertility decline. Although vitrification is highly efficient, reproductive success remains strongly dependent on maternal age and, on the number of cryopreserved oocytes. According to current literature, the number of oocytes required to achieve an approximately 75% probability of pregnancy ranges from about 12 in women <35 years to more than 60 in women aged ≥41 years. However, the extent to which EFP programmes account for these age-specific requirements in clinical practice remains unclear. Study design, size, duration This longitudinal epidemiological study was conducted between January 2014 and December 2024 at a single private assisted reproduction center in Latin America. Overall, 17,122 oocytes were vitrified across 2,151 elective fertility preservation cycles from 1,731 patients, of whom 278 subsequently warmed their oocytes for reproductive use. Patient characteristics, cryopreservation and warming cycle parameters, and reproductive outcomes after warming were evaluated over the study period. Participants/materials, setting, methods Patients were stratified according to age at EFP as follows: <35 years (EFP: n = 550; warming: n = 44), 35–37 years (EFP: n = 594; warming: n = 89), 38–40 years (EFP: n = 419; warming: n = 95), and ≥41 years (EFP: n = 168; warming: n = 50). Laboratory and clinical outcomes were compared across age groups. In addition, the number of vitrified oocytes was compared with age-specific thresholds proposed in the literature as sufficient to achieve a 75% probability of pregnancy. Main results and the role of chance Trends toward an increase in the mean number of cryopreserved oocytes per cycle (β = +0.22; p = 0.052) and in the annual number of EFP cycles (β = +37.8; p < 0.001) were observed. The utilization rate of cryopreservation cycles was 16.7%. Among warming cycles, oocyte survival improved over time, independently of female age (OR: 1.34; 95% CI 1.16–1.54). Blastocyst formation rates were lower in women ≥41 years (28.5%) compared with younger patients (42.6% in < 35, 46.2% in 35–37, and 41.4% in 38–40 years; p = 0.021). Transfer cancellation rates increased markedly with advancing age, affecting 40.7% of women <35 years and 44.1% of those aged 35–37 years, but rising to 72.3% and 92.9% in women aged 38–40 and ≥41 years (p < 0.001). Cumulative live birth rates also declined with advancing age (63.0%, 54.2%, 27.7%, and 7.1% for women <35, 35–37, 38–40, and ≥41 years respectively, p < 0.001). Only 60.2% of women < 35 years cryopreserved an adequate number of oocytes to achieve a ≥ 75% probability of live birth, compared with 9.6% of women aged 35–37 years and none of those ≥38 years. Among patients without embryos available for transfer or without live birth, 75–100% had cryopreserved an insufficient number of oocytes. Limitations, reasons for caution The retrospective design limits causal inference. Utilization rates may be underestimated due to ongoing oocyte storage. Adequacy thresholds are model-based and may not capture individual biological variability or evolving laboratory performance. As a single-centre study, generalizability to other settings may be limited. Wider implications of the findings These real-world data reveal a marked mismatch between current elective oocyte cryopreservation practices and the oocyte numbers required to achieve meaningful reproductive success, particularly at advanced maternal age, reinforcing the need for age-specific counselling, realistic expectation setting, and informed decision-making at the time of fertility preservation. Trial registration number No

Zitieren

APA

Valle, M. P., Lima, C., Andrade, T., Sampaio, M., Collado, M. D., & Oliveira, A. (2026). L26/P-445 Reproductive outcomes after elective oocyte cryopreservation: a 10-year epidemiological follow-up study of 17,122 cryopreserved oocytes in Latin America. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.779

Vancouver

Valle MP, Lima C, Andrade T, Sampaio M, Collado MD, Oliveira A. L26/P-445 Reproductive outcomes after elective oocyte cryopreservation: a 10-year epidemiological follow-up study of 17,122 cryopreserved oocytes in Latin America. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.779

BibTeX
@article{Valle2026,
  author = {Valle, M. Pereira and Lima, C. and Andrade, T. and Sampaio, M. and Collado, M. Del and Oliveira, A.},
  title = {L26/P-445 Reproductive outcomes after elective oocyte cryopreservation: a 10-year epidemiological follow-up study of 17,122 cryopreserved oocytes in Latin America},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.779}
}
Kostenlos starten →